2. THERAPEUTIC GOALS
DO NOT OVERTREAT A BENIGN
TUMOR
DO NOT UNDERTREAT A
MALIGNANT TUMOR
DO NOT MISDIRECT BIOPSY
3. RADIOLOGIST CAN SEE THE THREE
DIMENSIONAL GROSS PATHOLOGY
IF RADIOLOGIC FINDINGS ARE NOT
CORRELATING WITH THE PATHOLOGY
FINDINGS:SPECIAL STAINS, ADDITIONAL
IMAGES WILL HELP
TUMOR MAY HAVE VARYING HISTOLOGY
AND REPRESENTATIVE SAMPLE FROM
EPICENTRE OF THE LESION HAS TO BE
TAKEN
4. ROLE OF PLAIN
RADIOGRAPH
INITIAL EXAMINATION –STARTS THE
DIAGNOSTIC ALGORITHM
SCREENING, DETECTION,DIAGNOSIS,
FOLLOWUP
IN THIS COST-CONSCIOUS ERA
6. AGE AT PRESENTATION
DIFFERENTIAL DIAGNOSIS CAN BE NARROWED
1 ST DECADE :
NEUROBLASTOMA,LEUKEMIA
2 ND DECADE :
OSTEOSARCOMA, EWINGS SARCOMA
3RD DECADE:
GIANT CELL TUMOR
ELDERLY :
METASTASIS, CHONDROSARCOMA
CLUE TO AGE :
FROM EPIPHYSEAL FUSION
15. ZONE OF TRANSITION
IT IS AN ASSESSMENT OF THE
BIOLOGICAL ACTIVITY
GEOGRAPHIC OR TYPE 1 (LODWIG)
1A----WITH SCLEROSIS: BONE DEPOSITION
TO REDIRECT TRANSMITTED FORCES
IN TYPE 1A LESIONS IDEAL POSTOP
RADIOGRAPH SHOULD SHOW COMPLETE
REMOVAL OF NOT ONLY SCLEROTIC RIM
BUT ALSO SEVERAL MMS ―NORMAL
BONE‖
16. IF SCLEROTIC RIM REMAINS HIGHER
RECURRENCE CHANCE
EX: CHONDROBLASTOMA, BONE CYST
TYPE 1B:
BIOLOGIC ACTIVITY IS SLIGHTLY MORE:
NO SCLEROTIC RIM
EX: GIANT CELL TUMOR
17. TYPE 1CLESION
LYTIC LESION WITH ILL DEFINED
MARGIN: THEY ARE MALIGNANT
UNLESS PROVED OTHERWISE:
EX: CHONDROSARCOMA,
FIBROSARCOMA